Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ganzhou Bangda High-Tech Pharmaceutical is a pharmaceutical company based in Ganzhou, Jiangxi Province, China, specializing in the development and large-scale production of active pharmaceutical ingredients (APIs) and finished drug products. The company focuses heavily on the cardiovascular therapeutic area, with a primary product portfolio centered on statin medications used to manage cholesterol levels. Its core offerings include atorvastatin calcium and rosuvastatin calcium, which are manufactured in GMP-compliant facilities. Beyond finished dosages, the company is also involved in the synthesis of complex chemical intermediates for the global pharmaceutical supply chain. Ganzhou Bangda High-Tech Pharmaceutical serves both the domestic Chinese market and international clients through its integrated research and manufacturing capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 赣州邦达高科制药.